← Back to Search

Endovascular Graft

Abdominal - EVAR for Abdominal Aortic Aneurysm (TiGER Trial)

N/A
Recruiting
Research Sponsored by Vascutek Ltd.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Summary

Multi-arm, multi-center, open label, prospective observational registry designed to obtain safety and performance data on the use of CE marked and custom Terumo Aortic endovascular grafts.

Eligible Conditions
  • Abdominal Aortic Aneurysm
  • Thoracic Aortic Aneurysm
  • Surgery

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Aortic Related Mortality
Secondary outcome measures
Composite Clinical Success
Technical Success
Other outcome measures
Health Economics
Patient Outcome measure

Trial Design

4Treatment groups
Experimental Treatment
Group I: Thoracic - TEVARExperimental Treatment1 Intervention
Group II: Other indicationsExperimental Treatment1 Intervention
Isolated Iliac Artery Aneurysm (IIAA)
Group III: Custom DeviceExperimental Treatment1 Intervention
Group IV: Abdominal - EVARExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Vascutek Ltd.Lead Sponsor
16 Previous Clinical Trials
4,745 Total Patients Enrolled
Bolton MedicalIndustry Sponsor
16 Previous Clinical Trials
1,851 Total Patients Enrolled
~517 spots leftby Nov 2029
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top